An Immunologic Study of Treatment-Naive HIV Patients Starting a Darunavir/Ritonavir- or Efavirenz-Based HAART

Clinical trial NCT01541085 · COMPLETED

Trial details

NCT number: NCT01541085
Sponsor: Janssen-Cilag S.p.A.
Status: COMPLETED
Study type: OBSERVATIONAL

Human Immunodeficiency Virus; HIV

Start date: 2011-12-01
Primary completion: 2013-06-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.